FI860923A - I vatten dispergerbara och vattenloesliga polymerkompositioner foer parenteral administration. - Google Patents

I vatten dispergerbara och vattenloesliga polymerkompositioner foer parenteral administration. Download PDF

Info

Publication number
FI860923A
FI860923A FI860923A FI860923A FI860923A FI 860923 A FI860923 A FI 860923A FI 860923 A FI860923 A FI 860923A FI 860923 A FI860923 A FI 860923A FI 860923 A FI860923 A FI 860923A
Authority
FI
Finland
Prior art keywords
dispenser
polymer composition
parenteral administration
parenteral
administration
Prior art date
Application number
FI860923A
Other languages
English (en)
Finnish (fi)
Other versions
FI860923A0 (fi
Inventor
Susan Mancini Cady
Richard Fishbein
Ulf Schroeder
Hakan Eriksson
Brenda Lee Probasco
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8501094A external-priority patent/SE8501094D0/xx
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FI860923A0 publication Critical patent/FI860923A0/fi
Publication of FI860923A publication Critical patent/FI860923A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pens And Brushes (AREA)
  • Organic Insulating Materials (AREA)
FI860923A 1985-03-06 1986-03-05 I vatten dispergerbara och vattenloesliga polymerkompositioner foer parenteral administration. FI860923A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE8501094A SE8501094D0 (sv) 1985-03-06 1985-03-06 Biologiskt aktiv komposition och forfarande for framstellning derav
US71741785A 1985-03-29 1985-03-29
US83015886A 1986-02-20 1986-02-20

Publications (2)

Publication Number Publication Date
FI860923A0 FI860923A0 (fi) 1986-03-05
FI860923A true FI860923A (fi) 1986-09-07

Family

ID=27355321

Family Applications (1)

Application Number Title Priority Date Filing Date
FI860923A FI860923A (fi) 1985-03-06 1986-03-05 I vatten dispergerbara och vattenloesliga polymerkompositioner foer parenteral administration.

Country Status (11)

Country Link
EP (1) EP0193917A3 (de)
KR (1) KR890004687B1 (de)
AU (1) AU591478B2 (de)
DK (1) DK100686A (de)
ES (1) ES8704347A1 (de)
FI (1) FI860923A (de)
GR (1) GR860610B (de)
IL (1) IL78031A0 (de)
NO (1) NO860832L (de)
NZ (1) NZ215366A (de)
PT (1) PT82150B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786501A (en) * 1985-07-15 1988-11-22 International Minerals & Chemical Corp. Cylindrical implants for the controlled release of growth hormones
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
NZ235556A (en) * 1986-11-05 1991-06-25 Ethicon Inc Breast milk substitute containing recombinant human egf
US4857506A (en) * 1987-01-12 1989-08-15 American Cyanamid Company Sustained release growth hormone compositions for parenteral administration and their use
US4857505A (en) * 1987-03-09 1989-08-15 American Cyanamid Company Sustained release compositions for parenteral administration and their use
US4863736A (en) * 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
DE3782737T3 (de) * 1987-08-21 1999-05-20 Imcera Group Inc., Northbrook, Ill. Stabilisierung von Wachstumshormonen.
NZ226170A (en) * 1987-09-18 1990-07-26 Ethicon Inc Stable freeze-dried pharmaceutical composition containing epidermal growth factor
GB8725427D0 (en) * 1987-10-30 1987-12-02 Lilly Industries Ltd Somatotropin formulations
US5981485A (en) 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
US5763394A (en) * 1988-04-15 1998-06-09 Genentech, Inc. Human growth hormone aqueous formulation
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
FR2637501A1 (fr) * 1988-10-07 1990-04-13 Inst Develop Valorisa Biotec Composition stabilisee a base de facteurs de croissance de la famille fgf et de dextrane sulfate, et ses applications
CA2046324A1 (en) * 1989-01-26 1990-07-27 Wen-Ghih Tsang Stabilization of aqueous-based hydrophobic protein solutions and sustained release vehicle
US5422340A (en) * 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
AU653325B2 (en) * 1990-02-12 1994-09-29 Lucky Limited A composition durably releasing bioactive polypeptides
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
NZ234439A (en) * 1990-07-10 1997-08-22 Pharmacia & Upjohn Ab Use of igf-1 to reduce fetal growth retardation in non human mammals
US5714458A (en) * 1990-07-18 1998-02-03 Farmitalia Carlo Erba S.R.L. Stable pharmaceutical compositions containing a fibroblast growth factor
IE912345A1 (en) * 1990-08-03 1992-02-12 Pharmacia Ab Treatment of human lactation failure
GB9102107D0 (en) * 1991-01-31 1991-03-13 Erba Carlo Spa Stabilisation of fibroblast growth factor using a polysaccharide
US5192743A (en) * 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
RU2143889C1 (ru) * 1993-02-23 2000-01-10 Генентек, Инк. Способ стабилизации полипептида, способы получения композиций полипептида и композиции
ZA949350B (en) 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
ATE287431T1 (de) 2000-04-05 2005-02-15 Hafsteinn Helgason Gewinnung von verbindungen unter verwendung eines natuerlichen adsorbens
EP2700431A1 (de) 2012-08-24 2014-02-26 AnalytiCon Discovery GmbH Extrait végetal pour la modulation de TRPV1 fonction

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE396693B (sv) * 1970-02-16 1977-10-03 Paulsen Fredrik Sett att framstella komplex av syntetiskt kortikotropin med forsterkt och forlengd verkan
GB1345513A (en) * 1973-01-12 1974-01-30 Vosper Thornycroft Ltd Gas cushion vehicle
FR2265043A1 (en) * 1974-03-18 1975-10-17 Dietrich & Cie De Roasting oven with several spits - has single motor turning all spits together through common crank plate
DE2512943A1 (de) * 1974-04-02 1975-10-16 Sandoz Ag Verfahren zur herstellung protrahiert wirksamer injektionspraeparate
EP0085036A1 (de) * 1982-01-18 1983-08-03 Monsanto Company Verfahren zur Verbesserung der Rindermilchproduktion
US4457916A (en) * 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
EP0123291A2 (de) * 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Verfahren zur Stabilisierung von Interferon
JPS60258125A (ja) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
DE3500268A1 (de) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung

Also Published As

Publication number Publication date
PT82150B (pt) 1988-02-17
KR860006985A (ko) 1986-10-06
FI860923A0 (fi) 1986-03-05
KR890004687B1 (ko) 1989-11-25
NO860832L (no) 1986-09-08
DK100686A (da) 1986-09-07
EP0193917A3 (de) 1987-09-23
PT82150A (en) 1986-04-01
EP0193917A2 (de) 1986-09-10
NZ215366A (en) 1988-07-28
ES552690A0 (es) 1987-04-01
DK100686D0 (da) 1986-03-05
ES8704347A1 (es) 1987-04-01
GR860610B (en) 1986-06-30
AU591478B2 (en) 1989-12-07
AU5430686A (en) 1986-10-16
IL78031A0 (en) 1986-07-31

Similar Documents

Publication Publication Date Title
FI860923A0 (fi) I vatten dispergerbara och vattenloesliga polymerkompositioner foer parenteral administration.
EP0359531A3 (en) Cardioplegia administration set
FI862644A (fi) Tiazoler, deras framstaellning och dessa innehaollande farmaceutiska foereningar.
IT1209667B (it) Composizione effeverscente adattivita' analgesica.
NO862240D0 (no) Polymerblanding.
FI881070A0 (fi) Foerfarande i integrerad ir-tork/ yankeekaopa och ir-tork/yankeekaopa.
AU5512486A (en) Injection moulded dispenser
DE3685187D1 (de) Kontinuierlicher loetmittelspender.
DE3688458D1 (de) Polymerzusammensetzung.
FI865014A0 (fi) Foerbaettrad fast polymer elektrolytstruktur.
DK83485A (da) Laegemiddel indeholdende kvartaere 3,4-dihydroisochinoliniumsalte
FI861271A (fi) Polymeriserbar komposition.
FI860342A0 (fi) Polymeriserbara kompositioner.
DE3575664D1 (de) Selbstschliessende verabreichungsvorrichtung.
DE58907235D1 (de) Polymerisatmischung.
IS1371B6 (is) Lyfjaskammtari
DE68924645D1 (de) Verabreichungsmaschine.
FI870732A0 (fi) Glycero-3(2)-fosfo-l-serinderivat och deras salter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
NO864414D0 (no) Polymersammensetning.
FI894280A (fi) Foerbaettringar i blandningsapparater foer vaetskor och gaser.
FI863108A (fi) 3,7-disubstituerade 3-kefemfoereningar och foerfarande foer deras framstaellning.
IT8247665A0 (it) Composizione farmaceutica a base di derivanti di tiacromano, con proprieta' emobiologiche
DE3667915D1 (de) Pharmazeutische zusammensetzung.
FI894347A0 (fi) 2,3,4,5-tetrahydro-1-benzoxepiner, foerfarande foer deras framstaellning, deras anvaendning och dessa foereningar innehaollande farmaceutiska preparat.
FI861194A (fi) Substituerade 1,8-naftyridinoner, foerfarande foer deras framstaellning och farmaceutiska blandningar innehaollande dessa.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: AMERICAN CYANAMID COMPANY